Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
The PDE-5 inhibitor is preferably administered prior to the administration of PT-141
Insurance accepted.
Many GLP-1s are FDA approved for more than just weight loss, including type 2 diabetes, cardiovascular risk reduction, and even stroke prevention in certain populations, says Supriya Rao, MD, an obesity physician and the director of medical weight loss at Lowell General Hospital in Lowell, Massachusetts
Clinical studies show equivalent efficacy and tolerability, with additional advantages of flexible dosing, lower cost, and faster access without insurance delays
Although the study reports that the majority of these were mild/moderate (and only 4.5% discontinued treatment due to GI side effects) you do wonder if this had an impact on the weight loss
After lots of tests, it looks like a big step forward in fighting obesity
